Redeye is encouraged by Climeon's sale of one HP300 unit to NovaAlgoma Cement Carriers that was anno...
Systemair redovisade en rapport för verksamhetsårets andra kvartal som fick ett mycket positivt mott...
Northbaze Group AB has decided to carry out a fully guaranteed rights issue of units valued at appro...
Genom marknadsföringssatsningar, registrerat JV i Kina, ett breddat distributionsnätverk samt godkän...
CEO highlighted churn of 1.8% International content providers are key for growth Potential M&A oppor...
Synthetic MR har ett utmanande 2024 med nettoomsättning för Q3 på 13,3 MSEK (-39% YoY) fortsatt driv...
Signs of market improving from low levels Good activity with Aira, but new partnerships will take ti...
Prostatype Genomics förväntar sig svar inom kort från den amerikanska administrationen av Medicare o...
European recovery seems to continue Low market share and strong offering provide long runway for gro...
AcuCort AB (”AcuCort” eller ”Bolaget”) har under Q3-24 tagit viktiga steg i kommersialiseringsresan,...
Redeye is raising its near-term earnings forecasts on the back of strong Q2 numbers.
Redeye returns with a more in-depth take on the report following the conference call and chat with m...
Capitalising on the wave of infrastructure and defence investments 58% adj.
Redeye leaves a comment following Cinclus’ announcement of linaprazan glurate having received market...
The company upgraded its 2024 net sales guidance midpoint by 5% on December 4.
